Financials

  • Market Capitalization 72 M
  • Employee 7
  • Founded 2008
  • CEO Maria-luisa Maccecchini
  • Website www.annovisbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00PN9XD40
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4070
CING
Cingulate Inc. - Common Stock
5.14 USD-0.58%-10.92%+5.54%-16.56%74.74 M USD
4074
NRXS
Neuraxis, Inc. Common Stock
5.91 USD-1.34%-3.90%-8.09%+8.84%74.22 M USD
4098
MNOV
MediciNova, Inc. - Common Stock
1.45 USD+0.69%-7.64%+9.85%+11.54%71.37 M USD
4105
SPRO
Spero Therapeutics, Inc. - Common Stock
1.20 USD-1.64%-3.23%+1.69%-41.18%69.88 M USD

Noticias